PropThink: Galena: One of Biotech’s Most Vulnerable Names

[ACN Newswire] – On the surface, Galena Biopharma (NASDAQ:GALE) appears a late-stage oncology company focused on developing a promising breast cancer therapy. Beneath this mask, however, is a business rife with problems. … more

View todays social media effects on GALE

View the latest stocks trending across Twitter. Click to view dashboard